Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical povidone-iodine versus saline to reduce surgical site infection in chronically catheterized patients undergoing surgery for benign prostatic hyperplasia or urethral stricture
PACTR202511672164284Completed
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in surgical site infection (SSI) comparing Povidone-iodine group A with Saline group B (2 arms). Primary endpoint: Incidence of surgical site infection. Started Jan 2024; status: completed.
02
Drugs
povidone-iodinesaline
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on PACTR202511672164284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511672164284.